Rothschild & Co hires Alex Mironov and Matthew O’Donnell as Managing Directors in North America
Retrieved on:
Monday, August 7, 2023
General Health, Professional Services, Health, Finance, Alvogen, University, Executive officer, Dominic Lee, MBA, Pernix Therapeutics Holdings, U.S. Bancorp, Washington University in St. Louis, Rutgers University, Global Advisory Committee on Vaccine Safety, Business administration, DCM, Rothschild & Co, Ranbaxy Laboratories, Knowledge, Growth, COVI-VAC (U.S. COVID-19 vaccine), ECM, Olin Business School, Therapy, Pfizer, Pharmaceutical industry, Interior design, Health care, Biochemistry
Rothschild & Co announced today that Alex Mironov and Matthew O’Donnell have joined the Healthcare team as Managing Directors.
Key Points:
- Rothschild & Co announced today that Alex Mironov and Matthew O’Donnell have joined the Healthcare team as Managing Directors.
- The senior hires represent the continued growth of the healthcare franchise and expansion of the firm’s presence and capabilities in the Northeast region within the Global Advisory business in North America.
- They will report to Dominic Hollamby, Partner and Global Head of Healthcare, and Lee LeBrun, Partner and Head of Global Advisory, North America.
- Mr. Mironov brings over 20 years of global experience in the healthcare and pharmaceutical sectors, spanning business development, M&A and corporate strategy, to Rothschild & Co.